Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment

International Journal of Antimicrobial Agents

Volumn 35, Issue 1, 2010, Pages 62-67

  Katsarolis, Ioannis ^a   Poulakou, Garyphallia ^a   Athanasia, Sofia ^a   Kourea Kremastinou, Jenny ^b,c   Lambri, Niki ^a   Karaiskos, Elias ^a   Panagopoulos, Periklis ^a   Kontopidou, Flora V ^a   Voutsinas, Dionysios ^d   Koratzanis, Georgios ^e   Kanellopoulou, Maria ^e   Adamis, Georgios ^f   Vagiakou, Helen ^f   Perdikaki, Pigi ^g   Giamarellou, Helen ^a   Kanellakopoulou, Kyriaki ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^c Biomedicine Laboratories   (Greece)

^d TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^e SISMANOGLIO HOSPITAL   (Greece)

^f G GENNIMATAS GENERAL HOSPITAL   (Greece)

^g Primary Health Care Centre of Astros Kynourias   (Greece)

Author keywords

Co trimoxazole; Cystitis; Escherichia coli; Fluoroquinolones; Mecillinam; Nitrofurantoin; Resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFALOTIN; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; MECILLINAM; NALIDIXIC ACID; NITROFURANTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL STUDY; CYSTITIS; DEMOGRAPHY; DRUG USE; ESCHERICHIA COLI; FEMALE; GREECE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; QUESTIONNAIRE; URINALYSIS; URINE CULTURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CYSTITIS; FEMALE; GREECE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; URINE; YOUNG ADULT;

EID: 71049151497     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.08.018     Document Type: Article

References (22)

1. Nicolle L.E. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am 35 (2008) 1-12
2. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., and Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 29 (1999) 745-758
3. Hillier S., Bell J., Heginbothom M., Roberts Z., Dunstan F., Howard A., et al. When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data. J Antimicrob Chemother 58 (2006) 1303-1306
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. Document M100-S16. Wayne, PA: CLSI; 2006.
5. Tice A.D. Short-course therapy of acute cystitis: a brief review of therapeutic strategies. J Antimicrob Chemother 43 Suppl. A (1999) 85-93
6. Ti T.Y., Kumarasinghe G., Taylor M.B., Tan S.L., Ee A., Chua C., et al. What is true community-acquired urinary tract infection? Comparison of pathogens identified in urine from routine outpatient specimens and from community clinics in a prospective study. Eur J Clin Microbiol Infect Dis 22 (2003) 242-245
7. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113 Suppl. 1A (2002) 14-19
8. Kahlmeter G. ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 51 (2003) 69-76
9. Hooton T.M., Besser R., Foxman B., Fritsche T.R., and Nicolle L.E. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 39 (2004) 75-80
10. Gupta K., and Stamm W.E. Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. Int J Antimicrob Agents 19 (2002) 554-556
11. Guay D.R. Contemporary management of uncomplicated urinary tract infections. Drugs 68 (2008) 1169-1205
12. Hillier S., Roberts Z., Dunstan F., Butler C., Howard A., and Palmer S. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother 60 (2007) 92-99
13. Gupta K. Addressing antibiotic resistance. Am J Med 113 Suppl. 1A (2002) 29-34
14. Hooton T.M. Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection. Int J Antimicrob Agents 22 Suppl. 2 (2003) 65-72
15. Aubert G., Carricajo A., Fonsale N., and Vautrin A.C. Optimization of the use of ciprofloxacin. Pathol Biol (Paris) 57 (2009) 236-239
16. Arslan H., Azap O.K., Ergönül O., Timurkaynak F, and Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 56 (2005) 914-918
17. Gobernado M., Valdés L., Alós J.I., García-Rey C., Dal-Ré R., García-de-Lomas J., et al. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 20 (2007) 68-76
18. Johnson L., Sabel A., Burman W.J., Everhart R.M., Rome M., MacKenzie T.D., et al. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 121 (2008) 876-884
19. Graninger W. Pivmecillinam-therapy of choice for lower urinary tract infection. Int J Antimicrob Agents 22 Suppl. 2 (2003) 73-78
20. Naber K.G., Schito G., Botto B., Palou J., and Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol 54 (2008) 1164-1178
21. Arya S.C., and Agarwal N. Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int 103 (2009) 994-995
22. Gupta K., Hooton T.M., and Stamm W.E. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 135 (2001) 41-50